- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib for the treatment of thyroid cancer: an updated review
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 4, Pages 573-583
Publisher
Informa Healthcare
Online
2015-01-21
DOI
10.1517/14656566.2015.1005601
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
- (2015) Mingzhao Xing et al. JOURNAL OF CLINICAL ONCOLOGY
- Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials
- (2014) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms
- (2014) Sariah Liu et al. CANCER TREATMENT REVIEWS
- ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors
- (2014) Frédéric Illouz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer
- (2014) R. Dadu et al. ONCOLOGIST
- Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
- (2014) Ze-Feng Zhang et al. PLoS One
- Management of Sorafenib-Related Adverse Events: A Clinician’s Perspective
- (2014) Marcia S. Brose et al. SEMINARS IN ONCOLOGY
- Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer
- (2014) Jolanta Krajewska et al. Expert Opinion on Orphan Drugs
- Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
- (2014) Jayastu Senapati et al. Mediterranean Journal of Hematology and Infectious Diseases
- Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis
- (2013) Wei-Xiang Qi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis
- (2013) Chen-Tian Shen et al. ENDOCRINE-RELATED CANCER
- Toxic cardiomyopathy leading to fatal acute cardiac failure related to vandetanib: a case report with histopathological analysis
- (2013) Rafael Selbach Scheffel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- (2013) Mingzhao Xing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Cardiovascular Mortality in Patients With Differentiated Thyroid Carcinoma: An Observational Study
- (2013) Esther N. Klein Hesselink et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Tyrosine Kinase Inhibitor–Induced Thyroid Disorders: A Review and Hypothesis
- (2013) Noriko Makita et al. THYROID
- Response to Sorafenib in a Pediatric Patient with Papillary Thyroid Carcinoma with Diffuse Nodular Pulmonary Disease Requiring Mechanical Ventilation
- (2013) Pallavi Iyer et al. THYROID
- Mechanisms of TKI-induced diarrhea in cancer patients
- (2013) Joanne M. Bowen Current Opinion in Supportive and Palliative Care
- Sorafenib in metastatic thyroid cancer
- (2012) Jaume Capdevila et al. ENDOCRINE-RELATED CANCER
- Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study
- (2012) Sandra Feldt et al. EUROPEAN JOURNAL OF CANCER
- Sorafenib therapy decreases the clearance of thyrotropin
- (2012) Herman Verloop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis
- (2012) Wei-Xiang Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Meta-Analysis of Randomized Controlled Trials for the Incidence and Risk of Treatment-Related Mortality in Patients With Cancer Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors
- (2012) Fabio A.B. Schutz et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
- (2012) Sophie Leboulleux et al. LANCET ONCOLOGY
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Brain Metastasis from Follicular Thyroid Carcinoma: Treatment with Sorafenib
- (2012) Yan Shen et al. THYROID
- The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland
- (2012) Iain J. Nixon et al. THYROID
- Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
- (2012) Panayiotis Savvides et al. THYROID
- Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
- (2011) Marcia S Brose et al. BMC CANCER
- New Targeted Therapies for Thyroid Cancer
- (2011) Alessandro Antonelli et al. CURRENT GENOMICS
- Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population
- (2011) Merina Ahmed et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- ENDOCRINE TUMOURS: Approach to the patient with advanced differentiated thyroid cancer
- (2011) M Schlumberger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
- (2011) Maryse Brassard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport
- (2011) Doreen Braun et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib Induced Thyroiditis in Two Patients with Hepatocellular Carcinoma
- (2011) Leni van Doorn et al. THYROID
- Fatal Heart Failure After a 26-Month Combination of Tyrosine Kinase Inhibitors in a Papillary Thyroid Cancer
- (2011) Marie-Elisabeth Toubert et al. THYROID
- Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
- (2010) L. L. Carr et al. CLINICAL CANCER RESEARCH
- Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination
- (2010) Randa M. Abdulrahman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- Response to Sorafenib at a Low Dose in Patients with Radioiodine-Refractory Pulmonary Metastases from Papillary Thyroid Carcinoma
- (2010) Libo Chen et al. THYROID
- Thyroid Cancer: Current Molecular Perspectives
- (2010) Francesca Giusti et al. Journal of Oncology
- Tyrosine kinase inhibitors and the thyroid
- (2009) Steven I. Sherman BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
- (2009) W.J. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- Sorafenib-Related Hand-Foot Skin Reaction Improves, Not Worsens, with Continued Treatment
- (2009) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
- (2009) Hassane Izzedine et al. EUROPEAN JOURNAL OF CANCER
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- The Successful Use of Sorafenib to Treat Pediatric Papillary Thyroid Carcinoma
- (2009) Steven G. Waguespack et al. THYROID
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- Tyrosine kinase inhibitors and modifications of thyroid function tests: a review
- (2008) Frédéric Illouz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Chemotherapy with Doxorubicin in Progressive Medullary and Thyroid Carcinoma of the Follicular Epithelium
- (2008) A. Matuszczyk et al. HORMONE AND METABOLIC RESEARCH
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
- (2007) I. Tamaskar et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now